The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $16.00

Today's change0.00 0.00%
Updated October 23 1:55 PM -4GMT. Delayed by at least 15 minutes.
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $16.00

Today's change0.00 0.00%
Updated October 23 1:55 PM -4GMT. Delayed by at least 15 minutes.

Vanda Pharmaceuticals Inc unchanged

Vanda Pharmaceuticals Inc is unchanged today sitting at (U.S.)$16.00. Shares have lost 0.93% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 19.08% during the last year.

Key company metrics

  • Open(U.S.) $16.00
  • Previous close(U.S.) $16.00
  • High(U.S.) $16.10
  • Low(U.S.) $15.83
  • Bid / Ask(U.S.) $15.95 / (U.S.) $16.00
  • YTD % change+0.31%
  • Volume169,774
  • Average volume (10-day)478,173
  • Average volume (1-month)687,332
  • Average volume (3-month)545,159
  • 52-week range(U.S.) $12.70 to (U.S.) $18.99
  • Beta1.33
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.23
Updated October 23 1:55 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue42373838
Total other revenue--------
Total revenue42373838
Gross profit38333331
Total cost of revenue5457
Total operating expense44453939
Selling / general / administrative31302422
Research & development81187
Depreciation / amortization0023
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2-8-1-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-8-10
Income after tax-2-8-10
Income tax, total000--
Net income-2-8-10
Total adjustments to net income--------
Net income before extra. items-2-8-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-8-10
Inc. avail. to common incl. extra. items-2-8-10
Diluted net income-2-8-10
Dilution adjustment--------
Diluted weighted average shares45444444
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.17-0.01-0.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.17-0.01-0.01